Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 109

Results For "organ"

1984 News Found

Max Healthcare Institute completes acquisition of further stake in Eqova Healthcare
Healthcare | April 14, 2023

Max Healthcare Institute completes acquisition of further stake in Eqova Healthcare

The company had acquired 26,000 equity shares having face value of Rs. 10 each fully paid up of Eqova


Zydus receives final approval from the USFDA for Azithromycin Tablets
Drug Approval | April 11, 2023

Zydus receives final approval from the USFDA for Azithromycin Tablets

Azithromycin Tablets USP, 500 mg had annual sales of US $20 million in the United States


Calibre Chemicals takes over R&D activities of Tina Life Sciences
News | April 11, 2023

Calibre Chemicals takes over R&D activities of Tina Life Sciences

Calibre will enhance the pace of new product development and the breadth of its Custom Development and Manufacturing (CDMO) Service offerings.


Need of the hour is Indian Research, Data and Solution to Indian problems: Dr Jitendra Singh
News | April 10, 2023

Need of the hour is Indian Research, Data and Solution to Indian problems: Dr Jitendra Singh

He mentioned that Thyroid disorders are a common health problem in Jammu and Kashmir


AIIA hosts walkthrough for Working Group of C20 on Integrated Holistic Health
News | April 10, 2023

AIIA hosts walkthrough for Working Group of C20 on Integrated Holistic Health

MoU signed between AIIA and University of Amrita Vishwa Vidhyapeetham for collaboration in the field of Research and Academics in Ayurveda


Emcure Pharmaceuticals bags Merit Award at HIV Congress 2023
News | April 08, 2023

Emcure Pharmaceuticals bags Merit Award at HIV Congress 2023

The Award acknowledges Emcure's contribution in the field of HIV/AIDS to improve the quality of life of people living with HIV/AIDS.


Tillotts Pharma announces the launch of Octasa 1600 mg Tablets in Canada
News | April 08, 2023

Tillotts Pharma announces the launch of Octasa 1600 mg Tablets in Canada

The introduction of Octasa 1600 mg to the Canadian market is expected to increase the options for UC patients managed with mesalazine.


Inflation and declining FDA drug approvals will pose challenges for pharma contract manufacturers in 2023, says GlobalData
News | April 08, 2023

Inflation and declining FDA drug approvals will pose challenges for pharma contract manufacturers in 2023, says GlobalData

FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop


Apitoria Pharma  appoints Dr. Sanjay Chaturvedi as CEO
People | April 06, 2023

Apitoria Pharma appoints Dr. Sanjay Chaturvedi as CEO

Venkat Nageswar Chalasani has been appointed as an Independent Director of Apitoria Pharma with effect from April 4, 2023


Approx 800 million Indians do not have health coverage, says Expert
Healthcare | April 06, 2023

Approx 800 million Indians do not have health coverage, says Expert

Government hospitals like AIIMS, KGMC & many more as per day OPD patients are 18-25 thousand